Literature DB >> 23971655

Prevalence of viral hepatitis (B and C) serological markers in healthy working population.

José Luis Calleja-Panero, Elba Llop-Herrera, Montserrat Ruiz-Moraga, Juan de-la-Revilla-Negro, Eva Calvo-Bonacho, Fernando Pons-Renedo, José Luis Martínez-Porras, Dolores Vallejo-Gutiérrez, Carmen Arregui, Luis Abreu-García.   

Abstract

INTRODUCTION AND
OBJECTIVES: prevalence of viral hepatitis (B and C) changes geographically. Our aim was to determinate the prevalence of hepatitis B (HBV) and hepatitis C virus (HCV) serological markers in healthy working population and to describe the epidemiological characteristics associated to its presence.
METHODS: blood samples and epidemiological data of 5,017 healthy workers from Murcia and Madrid were recorded prospectively.
RESULTS: a total of 5,017 healthy volunteers participated. Mean age 39 ± 11 years, men predominance (73 %). Prevalence of serological markers of HCV and HBV was 0.6 % and 0.7 %. Age of patients with HCV antibody was significantly higher (43 + or - 9 years vs. 39 + or - 11 years; p = 0.03). We observed significant differences in liver test values (alanine aminotransferase [ALT] 64 ± 56 IU/L vs. 28 ± 20 IU/L; p < 0.001; aspartate aminotransferase [AST] (51 + or - 45 IU/L vs. 23 + or - 12 IU/L; p < 0.001) and in gamma-glutamyltransferase(GGT) value (104 + or - 122 IU/L vs. 37 + or - 46 IU/L; p < 0.001. The presence of HCV antibody was related significantly to previous transfusion (13 % vs. 5 %; p = 0.03), tattoos (29 % vs. 13 %; p < 0.01), intravenous drug addiction (13 % vs. 0.2 %; p < 0.001) and coexistence with people with positive HCV antibody (16 % vs. 4 %; p < 0.001). In HBV no differences in basal characteristics were observed with exception in AST values (29 + or - 15 IU/L vs. 23 + or - 12 IU/L; p < 0.01). Hepatitis B surface antigen (HBsAg) was related significantly to previous transfusion (15 % vs. 5 %; p < 0.01), tattoos (26 % vs. 14 %; p = 0.04) and coexistence with people with positive HBsAg (17 % vs. 4 %; p < 0.001).
CONCLUSIONS: Prevalence of serological markers in healthy working population is low. Risk factors for infection were previous transfusion and tattoos. Intravenous drug addiction was only a risk factor in HCV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23971655     DOI: 10.4321/s1130-01082013000500002

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  6 in total

1.  Epidemiology of hepatitis C viral infection in Faisalabad, Pakistan: a retrospective study (2010-2012).

Authors:  Muhammad Arif Maan; Fatma Hussain; Muhammad Jamil
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 2.  Hepatitis B virus and hepatitis C virus infection in healthcare workers.

Authors:  Nicola Coppola; Stefania De Pascalis; Lorenzo Onorato; Federica Calò; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2016-02-18

3.  Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study.

Authors:  R Boix; R Cano; P Gallego; F Vallejo; R Fernández-Cuenca; I Noguer; A Larrauri
Journal:  BMC Health Serv Res       Date:  2017-07-05       Impact factor: 2.655

4.  HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018.

Authors:  Leire Pérez-Latorre; Juan Berenguer; Rafael Micán; Marta Montero; Carmen Cifuentes; Teresa Puig; José Sanz; Oscar L Ferrero; Belén De La Fuente; Carmen Rodríguez; Sergio Reus; José Hernández-Quero; Gabriel Gaspar; Laura Pérez-Martínez; Coral García; Luis Force; Sergio Veloso; Marta De Miguel; Inmaculada Jarrín; Juan González-García
Journal:  Euro Surveill       Date:  2021-06

5.  Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients.

Authors:  Cedric Simillion; Nasser Semmo; Jeffrey R Idle; Diren Beyoğlu
Journal:  Metabolites       Date:  2017-10-08

Review 6.  Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.

Authors:  S H I Hofstraat; A M Falla; E F Duffell; S J M Hahné; A J Amato-Gauci; I K Veldhuijzen; L Tavoschi
Journal:  Epidemiol Infect       Date:  2017-09-11       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.